He said the vaccine for COVID-19 is being developed by Profectus BioSciences Inc in US, which was acquired by AurobindoPharmas subsidiary Auro Vaccines LLC.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ixCxmy
via IFTTT
COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020
He said the vaccine for COVID-19 is being developed by Profectus BioSciences Inc in US, which was acquired by AurobindoPharmas subsidiary Auro Vaccines LLC.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ixCxmy
via IFTTT
0 comments:
Post a Comment